KEGG icon

Drug interaction list


Query:
D02995  Asenapine maleate (JAN/USAN); Saphris (TN)

Interactions: 345 hits    [ ATC classification | Therapeutic category ]

C00220  Methylene blue; Methylthioninium chloride (P) unclassified
C07506  Propantheline (P) unclassified
C07521  Thiopental (P) unclassified
C07814  Homatropine (P) unclassified
D00049  Niacin (USP); Nicotinic acid (JP17/INN); Niacor (TN); Niaspan (TN) (P) unclassified
D00059  Levodopa (JP17/USP/INN); Dopar (TN) (P) Target: DRD2
D00068  Alcohol (USP); Anhydrous ethanol (JP17); Dehydrated ethanol; Ethyl alcohol; Dehydrated ethanol (TN) (P) unclassified
D00095  Epinephrine (USP/INN); Adrenaline (JP17); Adrenalin (TN); Auvi-q (TN); Epipen (TN) (CI,P) unclassified
D00113  Atropine (USP); Atropen (TN) (P) unclassified
D00131  Disulfiram (JP17/USP/INN); Antabuse (TN) (P) unclassified
D00136  Haloperidol (JP17/USP/INN); Haldol (TN) (P) Target: DRD2 / CYP inhibition: CYP2D6
D00138  Scopolamine (INN); Transderm scop (TN) (P) unclassified
D00147  Hyoscyamine (USP) (P) unclassified
D00186  Ciprofloxacin (JP17/USP/INN); CPFX; Cipro (TN) (P) unclassified
D00197  Reserpine (JP17/USP/INN); Apoplon (TN); Serpalan (TN) (P) unclassified
D00198  Rescinnamine (JAN/INN); Tsuruselpi S (TN) (P) unclassified
D00210  Norfloxacin (JP17/USP/INN); NFLX; Noroxin (TN) (P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2
D00224  Allopurinol (JP17/USP/INN); Zyloprim (TN) (P) unclassified
D00232  Anisotropine methylbromide (USAN); Octatropine methylbromide (INN); Methyloctatropine bromide (JAN); Valpin (TN); Valpin 50 (TN) (P) unclassified
D00253  Carbidopa hydrate and levodopa; Parcopa (TN); Sinemet (TN) (P) unclassified
D00270  Chlorpromazine (USP/INN); Thorazine (TN) (P) Target: DRD2 HTR2A HTR2C / CYP inhibition: CYP2D6
D00281  Clonidine (JAN/USP/INN); Catarpres-TTS (TN) (P) unclassified
D00294  Diazoxide (JAN/USP/INN); Hyperstat (TN); Proglycem (TN) (P) unclassified
D00310  Enoxacin (USAN/INN); ENX; Penetrex (TN) (P) unclassified
D00318  Famotidine (JP17/USP/INN); Fluxid (TN); Pepcid (TN) (P) CYP inhibition: CYP1A2
D00350  Itraconazole (JP17/USP); Itrizole (TN); Sporanox (TN) (P) unclassified
D00397  Tropicamide (JP17/USP/INN); Mydriacyl (TN) (P) unclassified
D00405  Methyldopa (USP); Methyldopa hydrate (JP17); Aldomet (TN) (P) unclassified
D00418  Minoxidil (JAN/USP/INN); Loniten (TN); Riup (TN); Rogaine (TN) (P) unclassified
D00426  Risperidone (JP17/USP/INN); Risperdal (TN) (P) Target: DRD2 HTR2A / CYP inhibition: CYP2D6
D00430  Secobarbital (USP/INN); Seconal (TN) (P) unclassified
D00465  Oxybutynin (USAN/INN); Anturol (TN); Oxytrol (TN) (P) unclassified
D00474  Primidone (JP17/USP/INN); Mysoline (TN) (P) unclassified
D00481  Propantheline bromide (JP17/USP/INN); Pro-banthine (TN) (P) unclassified
D00499  Pentobarbital (USP/INN); Nembutal (TN) (P) unclassified
D00500  Pentobarbital sodium (JAN/USP); Nembutal sodium (TN) (P) unclassified
D00502  Pergolide mesylate (USP); Pergolide mesilate (JAN); Permax (TN) (P) Target: DRD2
D00506  Phenobarbital (JP17/USP/INN); Luminal (TN) (P) unclassified
D00515  Nitroglycerin (JP17/USP); Glyceryl trinitrate; Minitran (TN); Nitro-bid (TN); Nitro-dur (TN); Nitromist (TN); Transderm-nitro (TN) (P) unclassified
D00540  Glycopyrrolate (USP); Glycopyrronium bromide (JAN/INN); Cuvposa (TN); Robinul (TN); Seebri breezhaler (TN) (P) unclassified
D00555  Amobarbital (JP17/INN); Isomytal (TN) (P) unclassified
D00559  Pramipexole dihydrochloride (USP); Pramipexole hydrochloride hydrate (JAN); Pramipexole dihydrochloride monohydrate; Mirapex (TN) (P) Target: DRD2
D00603  Timolol maleate (JP17/USP); Blocadren (TN); Istalol (TN); Timoptic (TN) (P) CYP inhibition: CYP2D6
D00604  Clonidine hydrochloride (JP17/USP); Catapres (TN) (P) unclassified
D00606  Guanfacine hydrochloride (JAN/USP); Intuniv (TN); Tenex (TN) (P) unclassified
D00608  Doxazosin mesylate (USP); Doxazosin mesilate (JP17); Cardura (TN) (P) unclassified
D00609  Prazosin hydrochloride (JP17/USP); Minipress (TN) (P) unclassified
D00611  Mecamylamine hydrochloride (USP); Inversine (TN) (P) unclassified
D00612  Trimetaphan camsilate (JAN/INN); Trimetaphan camsylate; Arfonad (TN) (P) unclassified
D00613  Fenoldopam mesylate (USP); Corlopam (TN) (P) unclassified
D00614  Sodium nitroprusside (USP); Sodium nitroprusside hydrate (JAN); Nitropress (TN) (P) unclassified
D00633  Dopamine hydrochloride (JP17/USP); Actopamin (TN); Intropin (TN) (P) Target: DRD2
D00646  Tolterodine (USAN/INN) (P) CYP inhibition: CYP2D6
D00661  Cevimeline hydrochloride (USAN); Cevimeline hydrochloride hydrate (JAN); Evoxac (TN); Saligren (TN) (P) CYP inhibition: CYP2D6
D00679  Ergotamine tartrate (JP17/USP); Ergomar (TN) (P) Target: HTR1A
D00698  Aprobarbital (INN); Alurate (TN) (P) unclassified
D00699  Butabarbital sodium (USP); Secbutabarbital sodium (INN); Butabarb (TN); Butisol sodium (TN) (P) unclassified
D00700  Mephobarbital (JAN/USP); Methylphenobarbital (INN); Mebaral (TN) (P) unclassified
D00701  Phenobarbital sodium (JAN/USP/INN); Luminal sodium (TN) (P) unclassified
D00707  Fomepizole (JAN/USAN/INN); Antizol (TN) (P) unclassified
D00712  Methohexital sodium (USP); Brevital sodium (TN) (P) unclassified
D00713  Thiamylal sodium (JP17); Surital (TN) (P) unclassified
D00714  Thiopental sodium (JP17/USP/INN); Pentothal (TN) (P) unclassified
D00715  Methscopolamine bromide (USP); Hyoscine methobromide (INN); Pamine (TN) (P) unclassified
D00716  Clidinium bromide (USP/INN); Quarzan (TN) (P) unclassified
D00717  Dicyclomine hydrochloride (JAN/USP); Dicycloverine hydrochloride; Bentyl (TN); Urispas (TN) (P) unclassified
D00719  Hyoscyamine sulfate (USP); Hyoscyamine sulfate dihydrate; Egacene (TN) (P) unclassified
D00720  Mepenzolate bromide (JP17/INN); Cantil (TN) (P) unclassified
D00721  Methanthelinium bromide (INN); Methantheline bromide; Banthine (TN) (P) unclassified
D00722  Oxybutynin chloride (USP); Oxybutynin hydrochloride (JAN); Ditropan (TN); Gelnique (TN) (P) unclassified
D00723  Tridihexethyl chloride (BAN); Pathilon (TN) (P) unclassified
D00762  Metyrosine (USP); Metirosine (JAN/INN); Demser (TN) (P) unclassified
D00774  Orphenadrine citrate (USP); Norflex (TN) (P) unclassified
D00778  Benztropine mesylate (USP); Benztropine mesilate (JAN); Cogentin (TN) (P) unclassified
D00779  Biperiden (JAN/USP/INN); Akineton (TN) (P) unclassified
D00780  Bromocriptine mesylate (USP); Bromocriptine mesilate (JP17); Parlodel (TN) (P) Target: DRD2
D00782  Procyclidine hydrochloride (USP); Kemadrin (TN) (P) unclassified
D00784  Ropinirole hydrochloride (JAN/USP); Requip (TN) (P) Enzyme: CYP1A2 / Target: DRD2
D00787  Trihexyphenidyl hydrochloride (JP17/USP); Artane (TN) (P) unclassified
D00789  Chlorpromazine hydrochloride (JP17/USP); Sonazine (TN) (P) Target: DRD2 HTR2A HTR2C / CYP inhibition: CYP2D6
D00809  Amitriptyline hydrochloride (JP17/USP); Elavil (TN) (P) CYP inhibition: CYP2D6
D00824  Fluvoxamine maleate (JP17/USP); Luvox (TN) (P) CYP inhibition: CYP1A2 CYP2D6
D00848  Dextromethorphan hydrobromide (USP); Dextromethorphan hydrobromide hydrate (JP17); Benylin DM (TN) (P) CYP inhibition: CYP2D6
D00874  Moxifloxacin hydrochloride (JAN/USP); MFLX; Avelox (TN); Vigamox (TN) (P) unclassified
D00960  Anastrozole (JAN/USP/INN); Arimidex (TN) (P) unclassified
D00987  Cabergoline (JAN/USP/INN); Cabaser (TN); Dostinex (TN) (P) Target: DRD2
D00996  Epinephrine hydrochloride (JAN); Adrenalin chloride (TN) (CI) unclassified
D01002  Cyclopentolate hydrochloride (JP17/USP); Cyclogyl (TN) (P) unclassified
D01003  Hexocyclium metilsulfate (INN); Hexocyclium methyl sulfate; Tral (TN) (P) unclassified
D01004  Homatropine hydrobromide (JP17/USP); Isopto homatropine (TN) (P) unclassified
D01005  Isopropamide iodide (JAN/USP/INN); Darbid (TN) (P) unclassified
D01006  Oxyphencyclimine hydrochloride (JAN); Daricon (TN) (P) unclassified
D01007  Propiverine hydrochloride (JP17); Bup-4 (TN); Mictonorm (TN) (P) unclassified
D01028  Ticlopidine hydrochloride (JP17/USP); Ticlid (TN) (P) unclassified
D01051  Spiperone (JAN/USAN); Spiropitan (TN) (P) Target: DRD2
D01071  Hexobarbital (JAN/INN) (P) unclassified
D01077  Methylatropine nitrate (USAN); Atropine methonitrate (JAN/INN); Ekomine (TN) (P) unclassified
D01103  Trospium chloride (JAN/USP/INN); Spasmex (TN); Spasmoplex (TN) (P) unclassified
D01118  Profenamine hydrochloride (JAN); Ethopropazine hydrochloride; Parkin (TN); Parsidol (TN) (P) unclassified
D01148  Tolterodine tartrate (JAN/USP); Detrol (TN); Detrusitol (TN) (P) CYP inhibition: CYP2D6
D01153  Pazufloxacin (JAN/INN); PZFX (P) unclassified
D01164  Aripiprazole (JAN/USP/INN); Abilify (TN) (P) Target: DRD2 HTR1A HTR2A / CYP inhibition: CYP2D6
D01165  Piperidolate hydrochloride (JAN); Dactil (TN) (P) unclassified
D01201  Tiemonium iodide (JAN/INN); Visceralgine (TN) (P) unclassified
D01224  Phenylpropanolamine hydrochloride (JAN/USP) (P) unclassified
D01227  Bosentan (USAN); Bosentan hydrate (JAN); Tracleer (TN) (P) unclassified
D01231  Piroheptine hydrochloride (JAN); Trimol (TN) (P) unclassified
D01269  Solifenacin succinate (JAN/USAN/INN); Vesicare (TN) (P) unclassified
D01277  Droxidopa (JP17/USAN/INN); Dops (TN); Northera (TN) (P) unclassified
D01297  Pirenzepine hydrochloride (USAN) (P) unclassified
D01302  Hydralazine hydrochloride (JP17/USP); Apresoline (TN) (P) unclassified
D01310  Secobarbital sodium (JAN/USP); Seconal sodium (TN) (P) unclassified
D01315  Methylbenactyzium bromide (JP17/INN) (P) unclassified
D01333  Urapidil (JP17/INN); Ebrantil (TN) (P) CYP inhibition: CYP2D6
D01348  Terguride (JAN/INN); Teluron (TN) (P) Target: DRD2
D01359  Etomidoline (JAN/INN); Smedolin (TN) (P) unclassified
D01377  Prifinium bromide (JAN/INN); Padrin (TN) (P) unclassified
D01382  Metharbital (JAN/INN); Gemonil (TN) (P) unclassified
D01451  Scopolamine butylbromide (JP17); Butylscopolamine bromide; Buscopan (TN) (P) unclassified
D01462  Lisuride maleate (JAN) (P) Target: DRD2
D01463  Diponium bromide (JAN/INN); Dipenine bromide (P) unclassified
D01482  Pipamperone hydrochloride (JAN) (P) Target: DRD2
D01491  Butropium bromide (JP17/INN); Coliopan (TN) (P) unclassified
D01505  Talipexole hydrochloride (JAN); Domin (TN) (P) Target: DRD2
D01521  Pipethanate hydrochloride (JAN); Glymor (TN) (P) unclassified
D01531  Pipemidic acid hydrate (JP17); PPA; Karunomazin (TN) (P) unclassified
D01538  Valethamate bromide (JAN); Shinmetane (TN) (P) unclassified
D01600  Diphenylpiperidinomethyldioxolan iodide (JAN); Anacolin; Gastrophyllin-A (TN) (P) unclassified
D01603  Bethanidine sulfate (JAN/USAN); Tenathan (TN) (P) unclassified
D01648  Hyoscyamine methylbromide (JAN) (P) unclassified
D01699  Darifenacin hydrobromide (JAN/USAN); Enablex (TN) (P) CYP inhibition: CYP2D6
D01740  Barbital (JP17/INN); Barbital (TN) (P) unclassified
D01804  Cadralazine (JP17/INN); Cadral (TN) (P) unclassified
D01815  Oxapium iodide (JP17/INN); Espalexan (TN) (P) unclassified
D01871  Methixene hydrochloride (USAN); Metixene hydrochloride (JAN); Methixene hydrochloride hydrete; Trest (TN) (P) unclassified
D01875  Tiquizium bromide (JAN/INN); Thiaton (TN) (P) unclassified
D01898  Haloperidol decanoate (JAN/USP); Halomonth (TN) (P) Target: DRD2 / CYP inhibition: CYP2D6
D01929  Tiotropium bromide hydrate (JAN); Tiotropium bromide monohydrate; Spiriva (TN) (P) unclassified
D01946  Oxitropium bromide (JAN/INN); Tersigan (TN) (P) unclassified
D01976  N-Methylscopolamine methylsulfate (JAN); Daipin (TN) (P) unclassified
D02004  Apomorphine hydrochloride (USP); Apomorphine hydrochloride hydrate (JAN); Apokyn (TN); Ixense (TN); Uprima (TN) (P) Target: DRD2
D02008  Tadalafil (JAN/USP/INN); Adcirca (TN); Cialis (TN); Zalutia (TN) (P) unclassified
D02069  Atropine sulfate (JP17/USP); Isopto Atropine (TN) (P) unclassified
D02070  Homatropine methylbromide (USP); Equipin (TN) (P) unclassified
D02071  Scopolamine hydrobromide (USP); Scopolamine hydrobromide hydrate (JP17); Scopolamine hydrobromide trihydrate; Hysco (TN); Isopto hyoscine (TN) (P) unclassified
D02135  Levodopa and benserazide hydrochloride; Madopar (TN) (P) unclassified
D02149  Epinephrine bitartrate (JAN/USP); Asmatane mist (TN); Medihaler-epi (TN) (CI) unclassified
D02211  Dihydroergotamine mesylate (USP); Dihydroergotamine mesilate (JP17); Migranal (TN) (P) unclassified
D02212  Ipratropium bromide (USP); Ipratropium bromide hydrate (JP17); Atrovent (TN) (P) unclassified
D02216  Ciprofloxacin hydrochloride (USP); Ciprofloxacin hydrochloride hydrate (JP17); CPFX; Ciloxan (TN); Cipro (TN); Proquin XR (TN) (P) unclassified
D02229  Sildenafil citrate (JAN/USP); Revatio (TN); Viagra (TN) (P) unclassified
D02237  Guanethidine sulfate (USAN) (P) unclassified
D02246  Biperiden hydrochloride (JP17/USP); Tasmolin (TN) (P) unclassified
D02247  Biperiden lactate (JAN/USP); Tasmolin (TN) (P) unclassified
D02252  Amobarbital sodium (JAN/USP); Amytal sodium (TN) (P) unclassified
D02253  Pentobarbital calcium (JP17); Ravona (TN) (P) unclassified
D02260  Paroxetine hydrochloride hemihydrate (USP); Paroxetine hydrochloride hydrate (JP17); Paxil (TN) (P) CYP inhibition: CYP2D6
D02312  Methylene blue (USP); Methylthioninium chloride; Methylthioninium chloride proveblue (TN) (P) unclassified
D02362  Paroxetine (USP/INN); Paroxetine (TN) (P) CYP inhibition: CYP2D6
D02363  Ketanserin (USAN/INN) (P) Target: HTR2A
D02417  Flutropium bromide (JAN); Flutropium bromide monohydrate; Flubron (TN) (P) unclassified
D02535  Timepidium bromide hydrate (JP17); Sesden (TN) (P) unclassified
D02564  Pargyline hydrochloride (USAN); Eutonyl (TN) (P) unclassified
D02574  Atomoxetine hydrochloride (JAN/USP); Tomoxetine hydrochloride; Strattera (TN) (P) CYP inhibition: CYP2D6
D02599  Orphenadrine hydrochloride; Disipal (TN) (P) unclassified
D02618  Butobarbital (BAN); Butethal; Neonal (TN) (P) unclassified
D02748  Peginterferon alfa-2b (USAN/INN); Peginterferon alfa-2b (genetical recombination) (JAN); Pegintron (TN); Sylatron (TN) (P) unclassified
D02775  Adrogolide hydrochloride (USAN) (P) unclassified
D02798  Alcohol diluted (NF) (P) unclassified
D02817  Allobarbital (USAN/INN) (P) unclassified
D02876  Alvameline maleate (USAN) (P) unclassified
D03087  Benzetimide hydrochloride (USAN); Dioxatrine (TN) (P) unclassified
D03165  Bromocriptine (USAN/INN) (P) Target: DRD2
D03180  Butabarbital (USP); Secbutabarbital (BAN) (P) unclassified
D03182  Butalbital (USP/INN); Sandoptal (TN) (P) unclassified
D03214  Aplindore fumarate (USAN) (P) Target: DRD2
D03260  Vardenafil hydrochloride hydrate (JAN); Vardenafil monohydrochloride trihydrate; Levitra (TN); Staxyn (TN) (P) unclassified
D03264  Mazaticol hydrochloride hydrate (JAN); Mazaticol hydrochloride; Pentona (TN) (P) unclassified
D03274  Chlorpromazine hibenzate (JAN); Contomin (TN) (P) Target: DRD2 HTR2A HTR2C / CYP inhibition: CYP2D6
D03276  Profenamine hibenzate (JAN); Parkin (TN) (P) unclassified
D03365  Nicotine (USP); Habitrol (TN) (P) CYP induction: CYP1A2
D03494  Ciladopa hydrochloride (USAN); Tremerase (TN) (P) Target: DRD2
D03654  Darifenacin (USAN/INN) (P) CYP inhibition: CYP2D6
D03664  Debrisoquin sulfate (USAN); Declinax (TN) (P) CYP inhibition: CYP2D6
D03669  Deferasirox (JAN/USAN/INN); Exjade (TN); Jadenu (TN) (P) CYP inhibition: CYP1A2
D03711  Dexetimide (USAN/INN); (+)-Benzetimide (P) unclassified
D03824  Dihexyverine hydrochloride (USAN) (P) unclassified
D03891  Dopexamine (USAN/INN) (P) Target: DRD2
D03892  Dopexamine hydrochloride (USAN); Dopacard (TN) (P) Target: DRD2
D03994  Endralazine mesylate (USAN); Endralazine monomethanesulfonate; Migranal (TN) (P) unclassified
D04034  Chlorpromazine phenolphthalinate (JAN); Wintermin (TN) (P) Target: DRD2 HTR2A HTR2C / CYP inhibition: CYP2D6
D04052  Epinephrine and lidocaine hydrochloride; Epinephrine and lidocaine hydrochloride; Xylocaine (TN) (CI,P) Enzyme: CYP1A2
D04057  Esoxybutynin chloride (USAN) (P) unclassified
D04077  Eterobarb (USAN/INN); Antilon (TN) (P) unclassified
D04087  Ethybenztropine (USAN); Etybenzatropine (INN); Panolid (TN) (P) unclassified
D04116  Eucatropine hydrochloride (USP XXXII) (P) unclassified
D04265  Reserpine, hydralazine hydrochloride and hydrochlorothiazide (P) unclassified
D04266  Benzylhydrochlorothiazide, Reserpine and Carbazochrome; Behyd RA (TN) (P) unclassified
D04340  Dextromethorphan hydrobromide and potassium cresolsulfonate; Medicon (TN) (P) CYP inhibition: CYP2D6
D04382  Guanethidine monosulfate (USP); Guanethidine sulfate (JP17); Ismelin (TN) (P) unclassified
D04386  Guanoclor sulfate (USAN); Vatensol (TN) (P) unclassified
D04398  Guanoxabenz (USAN/INN) (P) unclassified
D04399  Guanoxan sulfate (USAN); Envacar (TN) (P) unclassified
D04458  Hydralazine polistirex (USAN) (P) unclassified
D04479  Hyoscyamine hydrobromide (USP) (P) unclassified
D04488  Ibopamine (USAN/INN) (P) Target: DRD2
D04531  Indoramin (USAN/INN) (P) unclassified
D04532  Indoramin hydrochloride (USAN) (P) unclassified
D04693  Lergotrile (USAN/INN) (P) Target: DRD2
D04694  Lergotrile mesylate (USAN) (P) Target: DRD2
D04813  Lidocaine hydrochloride and epinephrine bitartrate; Ora (TN); Lidosite (TN) (P) Enzyme: CYP1A2
D04820  Lurasidone hydrochloride (JAN/USAN); SM 13496; Latuda (TN) (P) Target: DRD2 HTR2A
D04855  Ethanol for disinfection (JP17); Ethanol for disinfection (TN) (P) unclassified
D04868  Mebeverine hydrochloride (USAN) (P) unclassified
D04985  Methohexital (USP/INN) (P) unclassified
D05024  Mibefradil dihydrochloride (USAN); Posicor (TN) (P) unclassified
D05087  Moxonidine (USAN/INN); Cynt (TN) (P) unclassified
D05276  Pirenzepine hydrochloride hydrate (JP17); Gastrozepin (TN) (P) unclassified
D05374  Paroxetine hydrochloride (USP); Paxil (TN) (P) CYP inhibition: CYP2D6
D05375  Paroxetine mesylate (USAN); Brisdelle (TN); Pexeva (TN) (P) CYP inhibition: CYP2D6
D05382  Pazufloxacin mesilate (JP17); Pazufloxacin methanesulfonate; Pasil (TN) (P) unclassified
D05461  Enoxacin hydrate (JP17) (P) unclassified
D05466  Phenylpropanolamine polistirex (USAN) (P) unclassified
D05482  Pinacidil (USAN); Pinacidil hydrate; Pindac (TN) (P) unclassified
D05575  Pramipexole (USAN/INN) (P) Target: DRD2
D05677  Quinelorane hydrochloride (USAN) (P) Target: DRD2
D05682  Quinpirole hydrochloride (USAN) (P) Target: DRD2
D05705  Rauwolfia serpentina (USP); Rauwolfia extract; Himolfia (TN) (P) unclassified
D05768  Rotigotine (JAN/USAN/INN); Neupro (TN) (P) Enzyme: CYP1A2 / Target: DRD2
D05832  Sibenadet hydrochloride (USAN); Viozan (TN) (P) Target: DRD2
D05928  Stiripentol (JAN/USAN/INN); Diacomit (TN) (P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2
D06106  Thiamylal (P) unclassified
D06234  Trimazosin hydrochloride (USAN); Trimazosin hydrochloride monohydrate (P) unclassified
D06273  Imidafenacin (JAN/INN); Uritos (TN); Staybla (TN) (P) unclassified
D06405  Nalfurafine hydrochloride (JAN/USAN) (P) unclassified
D06542  Ethanol (JP17); Ethanol (TN) (P) unclassified
D06887  Talbutal (INN); Lotusate (TN) (P) unclassified
D07076  Camylofin (INN); Anafortan (TN) (P) unclassified
D07077  Ambrisentan (JAN/INN); Letairis (TN); Volibris (TN) (P) unclassified
D07099  Cimetropium bromide (JAN/INN); Alginor (TN) (P) unclassified
D07166  Methoserpidine (INN) (P) unclassified
D07167  Bietaserpine (prop.INN) (P) unclassified
D07168  Tolonidine (INN) (P) unclassified
D07169  Guanazodine (INN) (P) unclassified
D07170  Dihydralazine (INN) (P) unclassified
D07171  Sitaxentan (USAN/INN) (P) unclassified
D07217  Quinagolide (INN/BAN) (P) Target: DRD2
D07226  Fesoterodine (INN) (P) CYP inhibition: CYP2D6
D07298  Barbexaclone (INN); Maliasin (TN) (P) unclassified
D07301  Phenglutarimide (INN) (P) unclassified
D07302  Bornaprine (INN) (P) unclassified
D07303  Tropatepine (INN) (P) unclassified
D07305  Piribedil (INN); Trivastal (TN) (P) Target: DRD2
D07321  Vinylbital (INN); Vinylbitone (P) unclassified
D07322  Vinbarbital (INN) (P) unclassified
D07323  Cyclobarbital (INN); Ciclobarbital (TN) (P) unclassified
D07324  Proxibarbal (INN); Centralgol (TN) (P) unclassified
D07406  Pimethixene (INN); Calmixene (TN) (P) unclassified
D07460  Apomorphine (BAN); Uprima (TN) (P) Target: DRD2
D07505  Latanoprost and timolol maleate; Xalacom (TN) (P) unclassified
D07511  Benzatropine (INN); Benztropine (P) unclassified
D07513  Benzetimide (INN); Spasmental [veterinary] (TN) (P) unclassified
D07538  Bosentan (INN) (P) unclassified
D07564  Allopurinol sodium; Aloprim (TN) (P) unclassified
D07702  Ciprofloxacin lactate; Ciproxin (TN) (P) unclassified
D07757  Cyclobarbital calcium (BAN); Phanodorn calcium (TN) (P) unclassified
D07759  Cyclopentolate (INN); Bell Pentolate (TN) (P) unclassified
D07804  Dexetimide hydrochloride; Tremblex (TN) (P) unclassified
D07820  Dicycloverine (INN); Dicyclomine; Dicymine (TN) (P) unclassified
D07821  Dihexyverine (INN) (P) unclassified
D07830  Dihydralazine sulfate; Dihydralazine hydrogen sulfate; Nepresol (TN) (P) unclassified
D07837  Dihydroergotamine (INN); Neomigran (TN) (P) unclassified
D07838  Dihydroergotamine tartrate; Divegal (TN) (P) unclassified
D07870  Dopamine (INN); Medopa (TN) (P) Target: DRD2
D07874  Doxazosin (INN); Cardura XL (TN) (P) unclassified
D07906  Ergotamine (INN) (P) Target: HTR1A
D07946  Fenoldopam (INN); Carlacor (TN) (P) unclassified
D07951  Fentonium bromide (INN); Ulcesium (TN) (P) unclassified
D07984  Fluvoxamine (INN) (P) CYP inhibition: CYP2D6 CYP1A2
D08030  Guanethidine (INN) (P) unclassified
D08031  Guanfacine (INN); Estulic (TN) (P) unclassified
D08044  Hydralazine (INN); Hidral (TN) (P) unclassified
D08057  Ibopamine hydrochloride; Scandine (TN) (P) Target: DRD2
D08099  Ketanserin tartrate; Sufrexal (TN) (P) Target: HTR2A
D08132  Lisuride (INN) (P) Target: DRD2
D08157  Mazaticol (INN) (P) unclassified
D08160  Mebeverine (INN); Arluy (TN) (P) unclassified
D08194  Deserpidine (INN); Halmonyl (TN) (P) unclassified
D08205  Methyldopa (INN); Aldomet (TN) (P) unclassified
D08209  Metixene (INN) (P) unclassified
D08212  Trimazosin (INN) (P) unclassified
D08217  Mibefradil (INN) (P) unclassified
D08254  Endralazine (INN) (P) unclassified
D08287  Norfloxacin nicotinate; Quinabic soluble powder (TN) [veterinary] (P) Enzyme: CYP1A2 / CYP inhibition: CYP1A2
D08305  Orphenadrine (INN); Mialgin (TN) (P) unclassified
D08325  Oxyphencyclimine (INN) (P) unclassified
D08339  Pergolide (INN); Permax (TN) (P) Target: DRD2
D08356  Phenobarbital diethylamine; Gratusminal (TN) (P) unclassified
D08368  Phenylpropanolamine (INN); Fansia (TN) (P) unclassified
D08379  Pipemidic acid (INN); Nuril (TN) (P) unclassified
D08382  Piperidolate (INN) (P) unclassified
D08384  Pipethanate (INN); Piperilate (P) unclassified
D08389  Pirenzepine (INN) (P) unclassified
D08395  Piroheptine (INN) (P) unclassified
D08411  Prazosin (INN); Minipress (TN) (P) unclassified
D08425  Procyclidine (INN) (P) unclassified
D08426  Profenamine (INN) (P) unclassified
D08441  Propiverine (INN) (P) unclassified
D08453  Pargyline (INN) (P) unclassified
D08457  Quinagolide hydrochloride (BAN); Norprolac (TN) (P) Target: DRD2
D08482  Rilmenidine (INN); Hyperium (TN) (P) unclassified
D08489  Ropinirole (USAN/INN); Ropitor (TN) (P) Enzyme: CYP1A2 / Target: DRD2
D08493  Dorzolamide hydrochloride and timolol maleate; Cosopt (TN) (P) CYP inhibition: CYP2D6
D08517  Sitaxentan sodium (USAN); Thelin (TN) (P) unclassified
D08522  Solifenacin (INN) (P) unclassified
D08558  Talipexole (INN) (P) Target: DRD2
D08575  Tetrabenazine (JAN/INN); Nitoman (TN); Xenazine (TN) (P) Enzyme: CYP1A2 / CYP inhibition: CYP2D6
D08594  Ticlopidine (INN); Ticlopidin-Puren (TN) (P) unclassified
D08595  Tiemonium methylsulfate; Visceralgine (TN) (P) unclassified
D08638  Trihexyphenidyl (INN); Apo-trihex (TN) (P) unclassified
D08653  Tropatepine hydrochloride; Lepticur (TN) (P) unclassified
D08662  Urapidil hydrochloride; Ebrantil (TN) (P) CYP inhibition: CYP2D6
D08837  Aclidinium bromide (JAN/USAN/INN); Tudorza pressair (TN); Eklira genuair (TN) (P) unclassified
D08838  Acotiamide hydrochloride (USAN); Acotiamide hydrochloride hydrate (JAN) (P) unclassified
D08923  Fesoterodine fumarate (JAN/USAN); Toviaz (TN) (P) CYP inhibition: CYP2D6
D09402  Darotropium bromide (USAN/INN) (P) unclassified
D09572  Riociguat (JAN/USAN/INN); Adempas (TN) (P) unclassified
D09815  Travoprost and timolol maleate; Duotrav (TN) (P) unclassified
D09819  Chlorpromazine tannate (JAN) (P) Target: DRD2 HTR2A HTR2C / CYP inhibition: CYP2D6
D09894  Eliglustat tartrate (JAN/USAN); Eliglustat hemitartrate; Cerdelga (TN) (CI,P) CYP inhibition: CYP2D6
D09996  Vemurafenib (JAN/USAN/INN); Zelboraf (TN) (P) unclassified
D10135  Macitentan (JAN/USAN); Opsumit (TN) (P) unclassified
D10180  Umeclidinium (USAN) (P) CYP inhibition: CYP2D6
D10181  Umeclidinium bromide (JAN/USAN); Incruse ellipta (TN) (P) CYP inhibition: CYP2D6
D10185  Vortioxetine hydrobromide (JAN/USAN); Brintellix (TN); Trintellix (TN) (P) Target: HTR1A / CYP inhibition: CYP2D6
D10267  Methyldopa and hydrochlorothiazide; Methyldopa and hydrochlorothiazide (TN) (P) unclassified
D10293  Carbidopa, levodopa and entacapone; Stalevo (TN) (P) unclassified
D10298  Brimonidine tartrate and timolol maleate; Combigan (TN); Aibeta (TN) (P) unclassified
D10309  Brexpiprazole (JAN/USAN/INN); Rexulti (TN) (P) Target: DRD2 HTR1A HTR2A / CYP inhibition: CYP2D6
D10512  Brinzolamide and timolol maleate; Azorga (TN) (P) CYP inhibition: CYP2D6
D10516  Aripiprazole hydrate (JAN); Aripiprazole monohydrate (P) Target: DRD2 HTR1A HTR2A / CYP inhibition: CYP2D6
D10537  Methylthioninium chloride hydrate (JAN); Methylene blue (TN) (P) unclassified
D10569  Tafluprost and timolol maleate; Tapcom (TN) (P) unclassified
D10591  Clonidine and chlorthalidone; Clorpres (TN) (P) unclassified
D10822  Ciprofloxacin hydrate (JAN); Ciprofloxacin hemiheptahydrate (P) unclassified